This research document defines 'disease stability' as a new therapeutic indicator for chronic obstructive pulmonary disease (COPD) and verifies its clinical significance. Stability is presented as an ...
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) suggests escalating treatment in patients with chronic ...
Chronic obstructive pulmonary disease (COPD) is a persistent respiratory disease that may cause long-term, progressive lung damage. Acute exacerbations are when a person’s respiratory symptoms ...
Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. The disease, characterized by constricted airways due to bronchitis and emphysema, is commonly seen in smokers but ...
Please provide your email address to receive an email when new articles are posted on . 15.4% of the population had frequent exacerbations. Greater frequency was associated with higher corticosteroid ...
Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic ...
To examine the occurrence rate and health care cost of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) in Dutch general practice. Data are from the COPD on Primary ...
Please provide your email address to receive an email when new articles are posted on . Participants recorded their voice daily for 3 months. Of the 39 features analyzed, researchers found that 13 ...
Asthma exacerbations can be classified as mild, moderate, severe, or life threatening. Criteria for exacerbation severity are based on symptoms and physical examination parameters, as well as lung ...
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has highlighted recent advances in understanding and managing COPD, particularly in relation to its ...
Table 1 reports the total number of patients with COPD and the number experiencing an MI or stroke. There were 25,857 patients with COPD in 277 practices at the start of the observation period. Over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results